MedPath
FDA Approval

STRENSIQ

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 14, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Asfotase alfa(18 mg in 0.45 mL)

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

STRENSIQ

Product Details

NDC Product Code
25682-010
Application Number
BLA125513
Marketing Category
BLA (C73585)
Route of Administration
SUBCUTANEOUS
Effective Date
March 14, 2023
Code: Z633861EIMClass: ACTIBQuantity: 18 mg in 0.45 mL
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEInactive
Code: 70WT22SF4BClass: IACTQuantity: 2.48 mg in 0.45 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RNClass: IACTQuantity: 0.28 mg in 0.45 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 3.94 mg in 0.45 mL

STRENSIQ

Product Details

NDC Product Code
25682-016
Application Number
BLA125513
Marketing Category
BLA (C73585)
Route of Administration
SUBCUTANEOUS
Effective Date
March 14, 2023
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEInactive
Code: 70WT22SF4BClass: IACTQuantity: 5.5 mg in 1 mL
Code: Z633861EIMClass: ACTIBQuantity: 40 mg in 1 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RNClass: IACTQuantity: 0.62 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8.76 mg in 1 mL

STRENSIQ

Product Details

NDC Product Code
25682-019
Application Number
BLA125513
Marketing Category
BLA (C73585)
Route of Administration
SUBCUTANEOUS
Effective Date
March 14, 2023
Code: Z633861EIMClass: ACTIBQuantity: 80 mg in 0.8 mL
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEInactive
Code: 70WT22SF4BClass: IACTQuantity: 4.4 mg in 0.8 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RNClass: IACTQuantity: 0.5 mg in 0.8 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 7.01 mg in 0.8 mL

STRENSIQ

Product Details

NDC Product Code
25682-013
Application Number
BLA125513
Marketing Category
BLA (C73585)
Route of Administration
SUBCUTANEOUS
Effective Date
March 14, 2023
Code: Z633861EIMClass: ACTIBQuantity: 28 mg in 0.7 mL
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEInactive
Code: 70WT22SF4BClass: IACTQuantity: 3.85 mg in 0.7 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RNClass: IACTQuantity: 0.43 mg in 0.7 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 6.13 mg in 0.7 mL
© Copyright 2025. All Rights Reserved by MedPath